FFRangio System vs VX1+
AI Verdict
Choose FFRangio System if…
Choose the FFRangio System if you need a non-invasive, wire-free solution to assess coronary artery disease and optimize percutaneous coronary intervention (PCI) decisions. This tool is ideal for quickly obtaining accurate multi-vessel FFR results and advanced insights without the need for pressure wires or vasoactive drugs, streamlining your cath lab workflow for CAD patients.
View FFRangio System →Choose VX1+ if…
Choose VX1+ if you are an electrophysiologist performing cardiac ablation procedures for atrial fibrillation or atrial tachycardia and require real-time, AI-powered assistance. This software is best suited for identifying abnormal electrograms and spatio-temporal dispersed electrograms (DEs) to precisely guide ablation, enhancing procedural efficiency and outcomes.
View VX1+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | FFRangio System | VX1+ |
|---|---|---|
| Pricing | Contact vendor for pricing information. | Unknown |
| Deployment | SaaS, on-prem, hybrid | Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
FFRangio SystemThe FFRangio System boasts an intuitive user interface and seamless integration with cath lab equipment and PACS, with user testimonials highlighting its smooth workflow integration and user-friendliness after minimal training. While VX1+ also emphasizes a simple interface and fast learning curve, Tool A's documented comprehensive integration within the cath lab environment and positive user feedback give it a slight edge.
Clinical Value
FFRangio SystemThe FFRangio System offers significant clinical value by providing wire-free and drug-free FFR guidance with a diagnostic accuracy of 93% compared to invasive FFR, and has shown comparable one-year major adverse cardiac event rates. In contrast, while VX1+ has promising proof-of-concept study results, its FDA clearance explicitly states that the clinical significance of its software for improving ablation outcomes has 'not been established by clinical investigations.'
Pricing & Value
TieNeither tool provides publicly available pricing information, making a direct comparison of their cost-effectiveness impossible. Both products claim to offer value through improved procedural efficiency and reduced risks, but without specific financial data or detailed ROI studies, a definitive winner cannot be determined.
Enterprise Readiness
FFRangio SystemThe FFRangio System demonstrates strong enterprise readiness through its ISO 27001 and ISO 13485 certifications, indicating robust information security and quality management systems. Furthermore, its acquisition by Medtronic provides significant corporate backing and potential for broader integration and support within healthcare enterprises. While VX1+ is FDA cleared and CE marked, it does not explicitly state ISO 27001 certification.
Innovation
FFRangio SystemBoth tools are highly innovative, leveraging AI for real-time clinical decision support. However, the FFRangio System's 'wire-free and drug-free' approach to FFR measurement represents a more fundamental paradigm shift by transforming a previously invasive diagnostic procedure into a non-invasive one, directly reducing patient risk and discomfort.
Support & Docs
TieBoth companies provide essential support resources, including access to user manuals and contact information on their respective websites. There is insufficient information available to differentiate between the quality, breadth, or responsiveness of their support services or documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | FFRangio System | VX1+ |
|---|---|---|
| Name | FFRangio System | VX1+ |
| Company | CathWorks | Volta Medical |
| Primary Purpose | Delivers wire-free and drug-free 3D FFR guidance, providing accurate multi-vessel FFR results and advanced insights to quickly optimize and confirm PCI decisions for patients with coronary artery disease. | AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. |
| Target Medical Specialty | Cardiology | Cardiology |
| Key Feature (Example) | Real-time FFRangio values at every point on the coronary tree; Eliminates the need for invasive pressure wires, drugs, or a guide catheter. | Real-time manual or automatic annotation of 3D anatomical and electrical maps; Identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures. |
Videos
Demos, reviews, and walkthroughs featuring FFRangio System and VX1+.